CorMedix Inc. Quarterly Cost of Revenue in USD from Q1 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
CorMedix Inc. quarterly/annual Cost of Revenue history and growth rate from Q1 2013 to Q2 2024.
  • CorMedix Inc. Cost of Revenue for the quarter ending June 30, 2024 was $510K.
  • CorMedix Inc. annual Cost of Revenue for 2022 was $3.73K, a 97.5% decline from 2021.
  • CorMedix Inc. annual Cost of Revenue for 2021 was $149K, a 27.3% decline from 2020.
  • CorMedix Inc. annual Cost of Revenue for 2020 was $205K, a 45.1% decline from 2019.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $510K Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $819K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2022 $3.73K $406 -$47.6K -99.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 $51.3K $1.47K -$23.7K -94.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $75K $332 -$14.1K -97.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $89.1K $1.53K -$59.8K -97.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $149K $48K -$9.23K -16.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $158K $25.2K -$54.7K -68.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $213K $14.4K -$4.76K -24.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $218K $61.3K +$12.8K +26.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $205K $57.2K +$11.1K +24.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 $194K $79.9K +$887 +1.12% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $193K $19.2K -$1.94K -9.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $195K $48.5K -$178K -78.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $373K $46.1K +$24K +109% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-30
Q3 2019 $349K $79K -$233K -74.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $583K $21.1K -$12.5K -37.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $595K $227K +$198K +694% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $397K $22.1K +$85.4K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 $311K $312K +$246K +369% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $65.6K $33.7K +$15.6K +86.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $50K $28.6K -$65K -69.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q4 2017 $115K -$63.3K -$63.2K Oct 1, 2017 Dec 31, 2017 10-K/A 2019-05-29
Q3 2017 $178K $66.7K +$22.7K +51.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $155K $18.1K -$169K -90.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $325K $93.6K +$43.3K +86.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $281K -$85* +$79.00 Oct 1, 2016 Dec 31, 2016 10-K 2017-03-16
Q3 2016 $281K $43.9K +$44K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $237K $187K +$187K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $49.9K $50.2K +$50.2K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$318 -$164 +$273K +99.9% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-16
Q3 2015 -$274K -$35* +$36.6K Jul 1, 2015 Sep 30, 2015 10-K 2017-03-16
Q2 2015 -$310K -$102 +$54.4K +99.8% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-16
Q1 2015 -$365K -$17* +$81K Jan 1, 2015 Mar 31, 2015 10-K 2017-03-16
Q4 2014 -$446K -$274K -$72K -35.7% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 -$374K -$36.7K -$36.7K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$337K -$54.5K -$54.5K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 -$283K -$81K -$81K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 -$202K -$202K Oct 1, 2013 Dec 31, 2013 10-K 2015-03-12
Q3 2013 $0 Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 $0 Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 $0 Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.